JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

Search

ICU Medical Inc

Geschlossen

BrancheGesundheitswesen

125.24 2.22

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

120.4

Max

126.94

Schlüsselkennzahlen

By Trading Economics

Einkommen

51M

35M

Verkäufe

-56M

549M

Gewinnspanne

6.438

Angestellte

15,000

EBITDA

94M

106M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+37.29% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

6. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-167M

3B

Vorheriger Eröffnungskurs

123.02

Vorheriger Schlusskurs

125.24

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

ICU Medical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Nov. 2025, 23:10 UTC

Akquisitionen, Fusionen, Übernahmen

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4. Nov. 2025, 23:51 UTC

Ergebnisse
Wichtige Markttreiber

Arista Networks Expects Slowing Sales Growth, Worrying Investors -- Update

4. Nov. 2025, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. Nov. 2025, 23:48 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4. Nov. 2025, 23:42 UTC

Ergebnisse

Naver's Third-Quarter Earnings Rose on AI Push

4. Nov. 2025, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4. Nov. 2025, 23:30 UTC

Ergebnisse

Itau Unibanco 3Q Net BRL33.7B >ITUB

4. Nov. 2025, 23:25 UTC

Ergebnisse

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4. Nov. 2025, 23:25 UTC

Ergebnisse

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4. Nov. 2025, 23:24 UTC

Ergebnisse

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4. Nov. 2025, 23:23 UTC

Ergebnisse

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4. Nov. 2025, 23:06 UTC

Ergebnisse

Review & Preview: Tech Check -- Barrons.com

4. Nov. 2025, 22:52 UTC

Ergebnisse

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4. Nov. 2025, 22:33 UTC

Ergebnisse

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4. Nov. 2025, 22:29 UTC

Ergebnisse

Ashland 4Q Adj EPS $1.08 >ASH

4. Nov. 2025, 22:29 UTC

Ergebnisse

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4. Nov. 2025, 22:28 UTC

Ergebnisse

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4. Nov. 2025, 22:27 UTC

Ergebnisse

Ashland 4Q Cont Ops EPS 73c >ASH

4. Nov. 2025, 22:27 UTC

Ergebnisse

Ashland 4Q EPS 71c >ASH

4. Nov. 2025, 22:27 UTC

Ergebnisse

Ashland 4Q Sales $478M >ASH

4. Nov. 2025, 22:23 UTC

Ergebnisse

Ovintiv 3Q EPS 57c >OVV

4. Nov. 2025, 22:19 UTC

Market Talk

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4. Nov. 2025, 22:16 UTC

Ergebnisse

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4. Nov. 2025, 22:14 UTC

Akquisitionen, Fusionen, Übernahmen

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4. Nov. 2025, 22:13 UTC

Akquisitionen, Fusionen, Übernahmen

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4. Nov. 2025, 22:13 UTC

Akquisitionen, Fusionen, Übernahmen

Consortium: Able to Finance a Deal With Available Liquidity

4. Nov. 2025, 22:12 UTC

Akquisitionen, Fusionen, Übernahmen

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4. Nov. 2025, 22:11 UTC

Ergebnisse

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4. Nov. 2025, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4. Nov. 2025, 22:10 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

Peer-Vergleich

Kursveränderung

ICU Medical Inc Prognose

Kursziel

By TipRanks

37.29% Vorteil

12-Monats-Prognose

Durchschnitt 168.67 USD  37.29%

Hoch 180 USD

Tief 153 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ICU Medical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

3

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

137.16 / N/AUnterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Strong Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat